SANGUINE CORPORATION & SUBSIDIARY (A Development Stage Company) Consolidated Balance Sheets (Unaudited) (USD $)	Sep. 30, 2012	Dec. 31, 2011
CURRENT ASSETS
Cash	$ 4,902	$ 1,436
Total Current Assets	4,902	1,436
PROPERTY AND EQUIPMENT, NET	149	284
TOTAL ASSETS	5,051	1,720
CURRENT LIABILITIES
Accounts payable	270,764	261,814
Accrued interest	31,695	14,539
Accrued rent	2,700	0
Related party payable	500,821	357,641
Convertible promissory notes payable, net of debt discounts of $20,411 and $64,461, respectively	186,789	121,739
Total Current Liabilities	992,769	755,733
Total Liabilities	992,769	755,733
COMMITMENTS AND CONTINGENCIES
SHAREHOLDERS' DEFICIT
Preferred stock, 10,000,000 shares authorized of $0.001 par value, 75,000 and 75,000 shares issued and outstanding, respectively	75	75
Common stock, 200,000,000 shares authorized of $0.001 par value, 7,246,822 shares issued and outstanding, respectively	7,247	7,247
Stock subscription	25,000	0
Additional paid in capital	9,827,541	9,817,416
Deficit accumulated during the development stage	(10,847,581)	(10,578,751)
Total Shareholders' Deficit	(987,718)	(754,013)
TOTAL LIABILITIES AND SHAREHOLDERS' DEFICIT	$ 5,051	$ 1,720